N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide
C19H20FN5O5S — CID 122502494
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide
N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide (PubChem CID 122502494) has the molecular formula C19H20FN5O5S and a molecular weight of 449.46 g/mol. Its IUPAC name is N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide |
|---|---|
| PubChem CID | 122502494 |
| Molecular Formula | C19H20FN5O5S |
| Molecular Weight | 449.46 g/mol |
| Exact Mass | 449.12 |
| IUPAC Name | N-[5-(6-fluoro-8-hydroxy-2-morpholin-4-ylquinazolin-4-yl)-2-methoxy-3-pyridinyl]methanesulfonamide |
| SMILES | COc1ncc(-c2nc(N3CCOCC3)nc3c(O)cc(F)cc23)cc1NS(C)(=O)=O |
| InChI | InChI=1S/C19H20FN5O5S/c1-29-18-14(24-31(2,27)28)7-11(10-21-18)16-13-8-12(20)9-15(26)17(13)23-19(22-16)25-3-5-30-6-4-25/h7-10,24,26H,3-6H2,1-2H3 |
| InChIKey | XQMXPYAKLGKNIQ-UHFFFAOYSA-N |
| XLogP | 1.75 |
| TPSA | 126.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.46 |
| LogP ≤ 5 | 1.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122502494 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.